Pacific Biosciences of California, Inc. - Common Stock (NQ:PACB)

2.155 +0.045 (+2.13%)

Delayed Quote Updated: 10:35 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pacific Biosciences of California, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

2 Top Biotech Picks to Buy and Hold for the Next 10 Years ↗

May 29, 2021

Incredible scientific advances could reward investors -- if they have the patience.

Via The Motley Fool

Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake ↗

May 19, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the...

Via Benzinga

'SPACs Attack' Recap: Looking Back At 8 SPAC Deals Plus Latest SPAC Headlines And Earnings ↗

May 16, 2021

Last week featured eight announced SPAC deals. The week also had earnings from several well-known former SPACs. Here is a look back at the week that was SPACs for deals and...

Via Benzinga

Earnings Scheduled For April 29, 2021 ↗

April 29, 2021

Companies Reporting Before The Bell • OSI Systems (NASDAQ:OSIS) is estimated to report quarterly earnings at $1.33 per share on revenue of $290.51 million. •...

Via Benzinga

The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO ↗

May 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 17) Alexion Pharmaceuticals, Inc...

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

May 14, 2021

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...

Via Benzinga

3 Cathie Wood Stocks for a $150 Billion Market That's Just Forming ↗

May 13, 2021

Falling costs are ushering in a new era of screening for a dreaded disease.

Via The Motley Fool

Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase ↗

May 18, 2021

Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ:

Via Benzinga

What Investors Should Know About Ginkgo Bioworks SPAC Deal: 'Cell Programming Has The Potential To Impact Every Physical Goods Industry' ↗

May 11, 2021

A well seasoned SPAC management team announced a SPAC deal Tuesday to bring a cell programming company public. The SPAC Deal: Ginkgo Bioworks is going public in a SPAC deal with...

Via Benzinga

Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know ↗

May 16, 2021

Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and...

Via Benzinga

32 Stocks Moving In Monday's Mid-Day Session ↗

May 03, 2021

Gainers Regional Health Properties, Inc. (NYSE: RHE) shares jumped 99.7% to $14.42 after jumping 38% on Friday. Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) gained 30.5% to $64....

Via Benzinga

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗

May 14, 2021

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...

Via Benzinga

Why Pacific Biosciences of California Stock Is Down Today ↗

April 30, 2021

The company released its first-quarter earnings report, but that doesn't tell the whole story.

Via The Motley Fool

Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 30.17% to $1.42 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of...

Via Benzinga

52 Biggest Movers From Yesterday ↗

May 04, 2021

Gainers Regional Health Properties, Inc. (NYSE: RHE) shares climbed 102.5% to close at $14.62 on Monday after jumping 38% on Friday. Image Sensing Systems, Inc. (NASDAQ: ISNS)...

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 30, 2021

Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000...

Via Benzinga

55 Biggest Movers From Friday ↗

May 03, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7...

Via Benzinga

Pacific Biosciences of California (PACB) Q1 2021 Earnings Call Transcript ↗

April 30, 2021

PACB earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Pacific Biosciences: Q1 Earnings Insights ↗

April 29, 2021

Shares of Pacific Biosciences (NASDAQ:PACB) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 4600.00% over the past...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.